Abiopharma

News list

Director Miller Elizabeth Michelle 🟢 acquired 24.0K shares (3 derivative) of Usio, Inc. (USIO) Transaction Date: Jun 11, 2026 | Filing ID: 000951

Full text

News bot June 15, 2026, 10:31 p.m.
🔍 Miller Elizabeth Michelle (Director)

Company: Usio, Inc. (USIO)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 3
- Holdings reported: 0
- Total shares acquired: 24,000
Detailed Transactions and Holdings:
- Acquired 8,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | Exercise: 2027-06-11 | equity_swap_involved: 0 | shares_owned_after: 43,000.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 8,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | Exercise: 2028-06-11 | equity_swap_involved: 0 | shares_owned_after: 51,000.00 | transaction_form_type: 4 | Footnotes: F2
- Acquired 8,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | Exercise: 2029-06-11 | equity_swap_involved: 0 | shares_owned_after: 59,000.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Restricted Stock Units vests on 06/11/2027.
- F2: Restricted Stock Units vests on 06/11/2028.
- F3: Restricted Stock Units vests on 06/11/2029.